Skip to content

Mescaline: all studies

Page 90 of 97: studies 891 to 900 of 963, newest first. Back to the mescaline overview

Research

Microcrystalloscopic Differentiation of 3,4-Methylenedioxyamphetamine and Related Amphetamine Derivatives

Journal of Forensic Sciences May 1, 1991 Beryl B. Simpson, T. J. Simpson, Rh Liu

Abstract Commonly used gold chloride and its diluted forms are compared with gold bromide for potential microcrystalloscopic differentiation of 3,4-methylenedioxyamphetamine (MDA) and related amphetamine derivatives. The crystal formation characteristics of MDA, mescaline, and 2,5-dimethoxy-4-ethylamphetamine (DOET) with diluted and undiluted gold chloride allow differentiation of these drugs,...

Cross-Reactivity of Amphetamine Analogues with Roche Abuscreen Radioimmunoassay Reagents

Journal of Analytical Toxicology 1990 John T. Cody 22 citations

Cross-reactivity of amphetamine analogues with the Abuscreen amphetamine radioimmunoassay reagents was determined for both the standard and high specificity antibody systems. Compounds tested included 2-methoxyamphetamine, 4-hydroxymethamphetamine, 2,5-dimethoxyamphetamine (DMA), 4-bromo-2,5-dimethoxyamphetamine (DOB), 4-bromo-2,5-dimethoxy-beta-phenethylamine (BDMPEA),...

"Designer drugs"--a current perspective.

Journal of Emergency Medicine 1990 D A Jerrard

Since the late 1970s, in an effort to quench the ever burgeoning appetite for pharmacological substances of abuse and to satiate their own need for profit, unscrupulous chemists have set up clandestine laboratories to produce and market new drugs for street sale. Using fairly common industrial chemicals, they have altered or modified preexisting controlled substances such as fentanyl,...

Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.

Biological Psychiatry July 1, 1989 S J McClue, C Brazell, S M Stahl

We have assayed several phenylalkylamine and indolealkylamine hallucinogens, as well as structurally similar nonhallucinogens, for their effect on human platelet shape change, a physiological model for the central serotonergic 5-HT2 receptor. The hallucinogenic drugs lysergic acid diethylamide (LSD-25), N,N-dimethyltryptamine (N,N-DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeODMT),...

Discriminable effects of phencyclidine analogs evaluated by multiple drug (PCP versus OTHER) discrimination training.

Psychopharmacology 1989 D A Overton, C F Shen, G Y Ke et al.

This study tested structural analogs of phencyclidine (PCP) using drug discrimination procedures to determine which analogs produced discriminable effects similar to those of PCP. It also tested the utility of multiple-drug discrimination training (PCP versus other drugs or saline) as a method for increasing the specificity produced by training. All discrimination training took place in...

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Psychopharmacology 1989 L H Gold, C B Hubner, G F Koob

Methylenedioxymethamphetamine (MDMA) is a phenylethylamine with a chemical structure that resembles both the amphetamines and mescaline and has both stimulant and perception altering properties. The stimulant properties of MDMA were assessed in photocell cages designed to measure locomotor activity in rats. MDMA, over a range of doses (2.5-10.0 mg/kg, SC) produced locomotor hyperactivity which...

LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.

Progress in Neuro-Psychopharmacology and Biological Psychiatry 1989 P Carvey, P Nausieda, R Weertz et al.

1. We evaluated the behavioral response of guinea pigs to hallucinogenic agents in order to characterize the response of this species to a variety of known hallucinogenic drugs. 2. The systemic injection of LSD in the guinea pig elicited a "myoclonic-like" response the frequency of which was dose-dependent. This behavior exhibited rapid tolerance which was more prominent at higher doses. 3....

Clinical features and management of intoxication due to hallucinogenic drugs.

Medical toxicology and adverse drug experience 1989 J B Leikin, A J Krantz, M Zell-Kanter et al.

Hallucinogenic drugs are unique in that they produce the desired hallucinogenic effects at what are considered non-toxic doses. The hallucinogenic drugs can be categorised into 4 basic groups: indole alkaloid derivatives, piperidine derivatives, phenylethylamines and the cannabinols. The drugs reviewed include lysergic acid diethylamide (LSD), phencyclidine (PCP), cocaine, amphetamines,...

The effect of benzodiazepines on the 5-HT agonist-induced head-twitch response in mice.

European Journal of Pharmacology July 7, 1988 P C Moser, P H Redfern 21 citations

The effects of four benzodiazepines (diazepam, clonazepam, oxazepam and clobazam) were studied on the head-twitch response induced in mice by several 5-HT receptor agonists. All the benzodiazepines tested potentiated the effects of the directly acting agonists 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), quipazine and mescaline, without themselves inducing head-twitches. In contrast, none of...

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

Psychopharmacology 1988 C B Hubner, M Bird, S Rassnick et al.

3,4-Methylenedioxymethamphetamine (MDMA) is a psychoactive phenylisopropylamine which is structurally similar to both amphetamine-related sympathomimetics and the hallucinogen, mescaline. MDMA produces pleasurable effects which include euphoria, and recent reports continue to demonstrate its widespread recreational use. The aim of the present study was to assess the effects of racemic MDMA on...